# Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients

> **NCT06066554** · NA · UNKNOWN · sponsor: **Cairo University** · enrollment: 60 (estimated)

## Conditions studied

- Early Disease Onset

## Interventions

- **DEVICE:** Puva (psoralin and uva )

## Key facts

- **NCT ID:** NCT06066554
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-15
- **Primary completion:** 2024-05-15
- **Final completion:** 2024-05-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06066554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06066554, "Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06066554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*